Read our paper on the exome sequencing of 454,787 UK Biobank participants, published in nature. Our scientists continue to push the boundaries of genomics. Their work lights up our genome!

#ASHG21 Come see our exciting new work on associating the genetics of viral antigen response to risk of #glioma at my virtual poster session today 5:30-6:30pm EST. bit.ly/3AThIKY #PrgmNr3635

#ASHG2021 🧬 Come check out our exciting new work on breast cancer PRS and rare pathogenic variants in Latinas. Poster talk: ashg2021.ashg.org/sessions/23142…. Interactive poster session happening now (5:30-6:30 EST): ashg2021.ashg.org/posters/294544… #PrgmNr1409 #PrgmNr3630 Elad Ziv

#ASHG21 #session3 happening *live* now!

Have you heard about the Nigerian 100K genome project? Amazing results from the initial 1K whole-genome sequence of 50 tribal groups in Nigeria, presented by @codushlaine at #ASHG21. Exciting moment to see great science from the beloved motherland @weare54gene @AbasiEneobong

I have had an outstanding experience in the BMI program at UCSF and highly recommend anybody applying for PhDs this cycle (or just interested in what a comp bio PhD might look like) to consider attending this information session to learn more about the program!

Check out our #ASHG21 poster about the Black Representation in Genomics Research eQTL study. Also a couple of related 23andMe blog posts: blog.23andme.com/23andme-resear… blog.23andme.com/23andme-resear…

Happy to present our matters arising Nature Genetics re Tractor (Atkinson et al NG 2021). We argue that Tractor reduces GWAS power in admixed pops in realistic settings and we recommend caution when using it for GWAS in admixed pops. rdcu.be/cB2U7 🧵 1/

Three very exciting summer internship opportunities to work with my colleagues in the 23andMe #therapeutics #compbio group: bit.ly/3J5PBwM bit.ly/3IZgxOs bit.ly/3osH7rs

The last chapter of my thesis on genetic risk factors for developing multiple primary tumors is now on medRxiv! Through #WES data from UK Biobank and Kaiser Permanente Research NorCal, we identify potential pleiotropic variation in individuals with multiple cancers. John Witte lori sakoda

#PhDone !! I am overwhelmed by the amount of support I had during my exit talk. Thank you UCSF iPQB, UCSF Helen Diller Family Comprehensive Cancer Ctr, and Witte Lab for the fun memories.

exai bio turned 1 today! We were excited to celebrate this occasion with our amazing Exonauts.

NEW: Assessment of #GeneticSusceptibility to multiple primary #cancers through whole-exome #sequencing in two large #MultiAncestry studies Congrats Taylor Cavazos and Kaiser Permanente Research NorCal colleagues identifying potential pleiotropic variation - bit.ly/3T2Rzmp John Witte lori sakoda

If you are looking for a cutting-edge career in biotechnology, swing by our booth at the Stanford Career Fair on October 12 to learn about career opportunities.

Inclusion of variants discovered from diverse populations improves polygenic risk score transferability - read the full article by John S. Witte & Taylor Cavazos UC San Francisco HGGAdvances #ASHG22 hubs.li/Q01qqtcv0

Compelling new data at #SABCS2022 on the ability of the Exai oncRNA-based liquid biopsy platform to detect breast cancer in its earliest stages was presented by Taylor Cavazos Taylor Cavazos, PhD, Senior Scientist at Exai. #liquidbiopsy #innovation #patientcare

Seeing this made my day! ☺️